"Melanoma inhibitory activity" (MIA): A promising serological tumour marker in metastatic uveal melanoma

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 243, Issue 11, 2005, Pages 1161-1166

  Reiniger, Ingrid W ^a   Schaller, U C ^a   Haritoglou, C ^a   Hein, R ^b   Bosserhoff, A K ^c   Kampik, A ^a   Mueller, A J ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Melanoma inhibitory activity; Tumour marker; Uveal melanoma

Indexed keywords

BIOLOGICAL MARKER; GLOBULAR PROTEIN; LIVER ENZYME; MELANOMA INHIBITORY ACTIVITY PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER SCREENING; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOGRAPHY; ECHOOCULOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; TUMOR VOLUME; UVEA MELANOMA;

ADULT; AGED; AGED, 80 AND OVER; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM PROTEINS; PROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; UVEAL NEOPLASMS;

EID: 31144449655     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-005-1171-4     Document Type: Article

References (27)

1. Albert DM, Niffeneger AS, Willson JK (1992) Treatment of metastatic uveal melanoma: Review and recommendations. Surv Ophthalmol 36:429-438 10.1016/S0039-6257(05)80024-4
2. Blesch A, Bosserhoff AK, Apfel R, Behl C, Heßdörfer B, Schmitt A, Jachimczak P, Lottspeich F, Buettner R, Bogdahn U (1994) Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA. Cancer Res 54:5695-5701 7923218
3. Bosserhoff AK, Kaufmann M, Kaluza B, Bartke I, Zirngibl H, Hein R (1997) Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma. Cancer Res 57:3149-3153 9242442
4. Bosserhoff AK, Golob M, Buettner R, Landthaler M, Hein R (1998) MIA ("melanoma inhibitory activity"): Biologische Funktionen und klinische Relevanz beim malignen Melanom. Hautarzt 49:762-769 10.1007/ s001050050822
5. Bosserhoff AK, Moser M, Hein R, Landthaler M, Buettner R (1999) In situ expression patterns of melanoma-inhibiting activity (MIA) in: Melanomas and breast cancers. J Pathol 187:446-454 10.1002/ (SICI)1096-9896(199903)187:4<446::AID-PATH267>3.0.CO;2-Y
6. Collaborative Ocular Melanoma Study Group (COMS) (2004) Screening for metastasis from choroidal melanoma: The collaborative ocular melanoma study group. Report 23. J Clin Oncology 22:2438-2444
7. Diener-West M, Hawkins BS, Markowitz JA, Schachat AP (1992) A review of mortality from choroidal melanoma. A meta-analysis of 5-year mortality rates following enucleation. 1966 through 1988. Arch Ophthalmol 110:245-250 1531290
8. Egan KM, Seddon JM, Glynn RJ, Gragoudas ES, Albert DM (1988) Epidemiological aspects of uveal melanoma. Surv Ophthalmol 32:239-251 10.1016/0039-6257(88)90173-7
9. Eskelin S, Pyrhonen S, Summanen P, Prause JU, Kivela T (1999) Screening for metastatic malignant melanoma of the uvea revisited. Cancer 85:1151-1159 10.1002/ (SICI)1097-0142(19990301)85:5<1151::AID-CNCR20>3.0.CO;2-G
10. Folberg R, Mehaffey M, Gardner LM, Meyer M, Rummelt V, Pe'er J (1997) The microcirculation of choroidal and ciliary body melanomas. Eye 11:227-238 9349418
11. Gamel JW, McLean IW, McCurdy JB (1993) Biologic distinctions between cure and time to death in 2,892 patients with intraocular melanoma. Cancer 71:2299-2305 8453550
12. Goto H, Tenou T, Kudo H, Iwasaki T, Maramatsu R, Usui M, Wakamatsu K, Ito S (1998) 5-S-cysteinyldopa as a diagnostic tumor marker for uveal melanoma. Nippon Ganka Gakkai Zasshi 102:319-326 9619024
13. Haritoglou C, Neubauer AS, Herzum H, Freeman WR, Mueller AJ (2002) Interobserver and intraobserver variability of measurements of uveal melanomas using standardized echography. Br J Ophthalmol 86:1390-1394 10.1136/bjo.86.12.1390
14. Hicks C, Foss AJE, Hungerford JL (1998) Predictive power of screening tests for metastasis in uveal melanoma. Eye 12:945-948 10325992
15. Kan-Mitchell J, Liggett PE, Taylor CR, Rao N, Granada ESV, Danenberg KD, White WL, Van Eldik LJ, Horikoshi T, Danenberg PV (1993) Differential S100β expression in choroidal and skin melanomas: Quantitation by the polymerase chain reaction. Investig Ophthalmol Vis Sci 34:3366-3375
16. Kuan AK, Jackson FI, Hanson J (1988) Multimodality detection of metastatic melanoma. J R Soc Med 81:579-582 3054099
17. McLean I, Forster W, Zimmerman L (1980) Choroidal melanoma. Arch Ophthalmol 98:1298-1303 7396787
18. Metz CE (1978) Basic principles of ROC analysis. Semin Nucl Med 8:283-298 112681
19. Mooy CM, De Jong PTVM (1996) Prognostic parameters in uveal melanoma: A review. Surv Ophthalmol 41:215-228 10.1016/S0039-6257(96)80024-5
20. Mueller AJ, Bartsch DU, Schaller UC, Freeman WR, Kampik A (2001) Imaging the microcirculation of untreated and treated human choroidal melanomas. Ophthalmology 23:385-393
21. Mueller AJ, Freeman WR, Schaller UC, Kampik A, Folberg R (2002) Complex microcirculation patterns detected by confocal indocyanine green angiography predict time to growth of small choroidal melanocytic tumors. Ophthalmology 109:2207-2214 10.1016/S0161-6420(02)01266-6
22. Ossoinig KC, Bigar F, Kaefring SL (1975) Malignant melanoma of the choroid and the ciliary body: Differential diagnosis in clinical echography. Ultrasonography in ophthalmology, Basel, Karger 83:141-154
23. Pach JM, Robertson DM (1986) Metastasis from untreated uveal melanomas. Arch Ophthalmol 104:1624-1625 3778275
24. Rummelt V, Folberg R, Woolson RF, Hwang T, Pe'er J (1995) Relation between the microcirculation architecture and the aggressive behaviour of ciliary body melanomas. Ophthalmology 102:844-851 7777286
25. Schaller UC, Mueller AJ, Bosserhoff AK, Haraida S, Löhrs U, Buettner R, Kampik A (2000) Melanoma inhibitory activity (MIA): Evaluierung eines neuen tumorassoziierten Antigens als Serummarker für uveale Melanome. Ophthalmologe 97:429-432
26. Schaller UC, Bosserhoff AK, Neubauer AS, Buettner R, Kampik A, Mueller AJ (2002) Melanoma inhibitory activity: A novel serum marker for uveal melanoma. Melanoma Res 12:593-599 10.1097/00008390-200212000-00009
27. Terheyden P, Kämpgen E, Rünger TM, Bröcker EB, Becker JC (1998) Immunochemotherapie des metastasierenden Uveamelanoms mit Interferon-α2b, Interleukin-2 und Fotemustin: Kasuistiken und Literaturübersicht. Hautarzt 49:770-773 10.1007/s001050050823